/Companies

Gracellbio

Suzhou, CN · 10 known investors

Find your way into Gracellbio

Sign up to see every warm intro you have to Gracellbio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Gracellbio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Gracell Biotechnologies develops cell therapy manufacturing platforms and treatments, with a focus on CAR-T cell therapies for cancer and autoimmune diseases. The company operates manufacturing facilities in China and was acquired by AstraZeneca in February 2024.

Founders & leadership

WWWilliam Wei Cao
William Wei CaoExecutive Officer, Director at Cellular Biomedicine Group

Investors · 10

Frequently asked questions

What does Gracellbio do?
Gracell Biotechnologies develops cell therapy manufacturing platforms and treatments, with a focus on CAR-T cell therapies for cancer and autoimmune diseases. The company operates manufacturing facilities in China and was acquired by AstraZeneca in February 2024.
Who founded Gracellbio?
Gracellbio was founded by William Wei Cao.
Who are Gracellbio's investors?
Gracellbio's investors include LAV, Lilly Asia Ventures, OrbiMed, Pivotal Life Sciences, Exome Asset Management, Janus Henderson Investors, RA Capital, Temasek and 2 more.
Where is Gracellbio headquartered?
Gracellbio is headquartered in Suzhou, CN.